A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF

Blood

Volumn 94, Issue 11, 1999, Pages 3737-3747

  Hoatlin, Maureen E ^a   Yu, Zhi ^b   Ball, Helen ^b   Silvey, Kirsten ^b   Melnick, Ari ^b   Stone, Stacie ^b   Arai, Sally ^b   Hawe, Nicola ^b   Owen, Gareth ^b   Zelent, Arthur ^b   Licht, Jonathan D ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ZINC FINGER PROTEIN;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; FANCONI ANEMIA; HEMATOPOIESIS; HUMAN; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0345534801     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3737     Document Type: Article

References (83)

1. Fanconi G: Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects. Semin Hematol 4:233, 1967
2. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD: Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry study. Blood 84:1650, 1994
3. Strathdee CA, Buchwald M: Molecular and cellular biology of Fanconi anemia. Am J Pediatr Hematol Oncol 14:177, 1992
4. Auerbach A, Buchwald M, Joenje H: Fanconi Anemia, in Vogelstein B, Kinzler KW (eds): The Genetic Basis of Human Cancer. New York, NY, McGraw Hill, 1997
5. Liu JM, Buchwald M, Walsh CE, Young NS: Fanconi anemia and novel strategies for therapy. Blood 84:3995, 1994
6. Dutrillaux B, Aurias A, Dutrillaux AM, Buriot D, Prieur M: The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 62:327, 1982
7. Kaiser TN, Lojewski A, Dougherty C, Juergens L, Sahar E, Latt SA: Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment. Cytometry 2:291, 1982
8. Kinzler KW, Vogelstein B: Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386:761, 1997
9. Joenje H, Oostra AB, Wijker M, di Summa FM, van Berkel CG, Rooimans MA, Ebell W, van Weel M, Pronk JC, Buchwald M, Arwert F: Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 61:940, 1997
10. Buchwald M: Complementation groups: One or more per gene? Nat Genet 11:228, 1995
11. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356:763, 1992
12. de Winter JP, Waisfisz Q, Rooimans MA, van Berkel CG, Bosnoyan-Collins L, Alon N, Carreau M, Bender O, Demuth I, Schindler D, Pronk JC, Arwert F, Hoehn H, Digweed M, Buchwald M, Joenje H: The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet 20:281, 1998
13. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, van Berkel CG, Strunk MH, Gille JJ, Pals G, Kruyt FA, Pronk JC, Arwert F, Buchwald M, Joenje H: Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 14:320, 1996
14. Whitney MA, Saito H, Jakobs PM, Gibson RA, Moses RE, Grompe M: A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 4:202, 1993
15. Waisfisz Q, Saar K, Morgan NV, Altay C, Leegwater PA, de Winter JP, Komatsu K, Evans GR, Wegner RD, Reis A, Joenje H, Arwert F, Mathew CG, Pronk JC, Digweed M: The Fanconi Anemia Group E gene, FANCE, maps to chromosome 6p. Am J Hum Genet 64:1400, 1999
16. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD: The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 91:6712, 1994
17. Youssoufian H: Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 91:7975, 1994
18. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD: The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet 17:487, 1997
19. Hoatlin ME, Christianson TA, Keeble WW, Hammond AT, Zhi Y, Heinrich MC, Tower PA, Bagby GC, Jr: The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood 91:1418, 1998
20. Kupfer G, Yamashita T, Naf D, Suliman A, Asano S, D'Andrea A: The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 90:1047, 1997
21. Hoshino T, Wang J, Devetten MP, Iwata N, Kajigaya S, Wise RJ, Liu JM, Youssoufian H: Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood 91:4379, 1998
22. Kruyt FA, Hoshino T, Liu JM, Joseph P, Jaiswal AK, Youssoufian H: Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 92:3050, 1998
23. Garcia-Higuera I, Kuang Y, D Naf, Wasik J, D'Andrea AD: Fanconi Anemia Proteins FANCA, FANCC, and FANCG/XRCC9 interact in a Functional Nuclear Complex. Mol Cell Biol 19:4866, 1999
24. Waisfisz Q, de Winter JP, Kruyt F, de Groot J, van der Weel L, Dijkmans L, Zhi Y, Arwert F, Scheper R, Youssoufian H, Hoatlin M, Joenje H: Evidence for a physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci USA 96:10320, 1999
25. Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D: The BTB/POZ domain: A new protein-protein interaction motif common to DNA-and actin-binding proteins. Cell Growth Differ 6:1193, 1995
26. Bardwell VJ, Treisman R: The POZ domain: A conserved protein-protein interaction motif. Genes Dev 8:1664, 1994
27. Melnick A, Licht J: Deconstructing a disease: RAR α, its fusion proteins and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167, 1999
28. Hong SH, David G, Wong CW, Dejean A, Privalsky ML: SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:9028, 1997
29. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S, Zelent A: Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12:1161, 1993
30. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP: Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat Genet 18:126, 1998
31. David G, Alland L, Hong SH, Wong CW, DePinho RA, Dejean A: Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16:2549, 1998
32. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A: Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML-and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91:2634, 1998
33. Baron BW, Nucifora G, McCabe N, Espinosa R 3d, Le Beau MM, McKeithan TW: Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27; q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262, 1993
34. Chen SJ, Zelent A, Tong JH, Yu HQ, Wang ZY, Derre J. Berger R, Waxman S, Chen Z: Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J Clin Invest 91:2260, 1993
35. Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller WH Jr, Zelenetz AD, Wilman CL, Chen Z, Chen S-J, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjian H, Waxman S: Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85:1083, 1995
36. Miki T, Kawamata N, Arai A, Ohashi K, Nakamura Y, Kato A, Hirosawa S, Aoki N: Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood 83:217, 1994
37. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS, Dalla-Favera R: Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747, 1993
38. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM: Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589, 1997
39. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R: The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161, 1997
40. Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R, Zelent A: Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86:4544, 1995
41. Davies JM, Hawe N, Kabarowski J, Huang QH, Zhu J, Brand NJ, Leprince D, Dhordain P, Cook M, Morriss-Kay G, Zelent A: Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18:365, 1999
42. Grimm C, Sporle R, Schmid TE, Adler ID, Adamski J, Schughart K, Graw J: Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome. Hum Mol Genet 8:697, 1999
43. Hawe N, Soares V, Niswander L, Cattoretti G, Pandolfi P: Targeted disruption of the PLZF gene of acute promyelocytic leukemia results in phocomelia and altered spermatogenesis. Blood 88:1151, 1996 (abstr)
44. Oi VT, Herzenberg L: Immunoglobulin-producing hybrid cell lines, in Mishell B, Shiigi SM (eds): Selected Methods in Cellular Immunology. New York, NY, W. H. Freeman and Company, 1980, p 351
45. Durfee T, Becherer K, Chen P, Yeh P, Yang Y, Kilburn A, Lee W, Elledge S: The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7:555, 1993
46. James P, Halladay J, Craig EA: Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144:1425, 1996
47. Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A, Waxman S: Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene 12:323, 1996
48. Statview Reference Software. Cary, NC, SAS Institute, 1998
49. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York, NY, Wiley, 1989
50. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991
51. Li X, Lopez-Guisa JM, Ninan N, Weiner EJ, Rauscher FJ, 3rd, Marmorstein R: Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein. J Biol Chem 272:27324, 1997
52. Ball H, Melnick A, Shaknovich R, Kohanski R, Licht JD: The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. Nucleic Acids Res 27:4106, 1999
53. Buchwald M, Moustacchi E: Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat Res 408:75, 1998
54. Gillio AP, Verlander PC, Batish SD, Giampietro PF, Auerbach AD: Phenotypic consequences of mutations in the Fanconi anemia FAC gene: An International Fanconi Anemia Registry study. Blood 90:105, 1997
55. Whitney MA, Jakobs P, Kaback M, Moses RE, Grompe M: The Ashkenazi Jewish Fanconi anemia mutation: Incidence among patients and carrier frequency in the at-risk population. Hum Mutat 3:339, 1994
56. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389, 1997
57. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 215:403, 1990
58. Zollman S, Godt D, Prive G, Couder JL, Laski F: The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc Natl Acad Sci USA 91:10717, 1994
59. Daniel JM, Reynolds AB: The catenin p120(ctn) interacts with kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19:3614, 1999
60. Ahmad KF, Engel CK, Prive GG: Crystal structure of the BTB domain from PLZF. Proc Natl Acad Sci USA 95:12123, 1998
61. Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A, Chen S-J: Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc Natl Acad Sci USA 93:3624, 1996
62. Li JY, English MA, Ball HJ, Yeyati PL, Waxman S, Licht JD: Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J Biol Chem 272:22447, 1997
63. Sitterlin D, Tiollais P, Transy C: The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain. Oncogene 14:1067, 1997
64. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R, III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, Diaz MO: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735, 1991
65. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E: The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71:701, 1992
66. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691, 1992
67. Djabali M, Selleri L, Parry P, Bower M, Young BD, Evans GA: A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias [published erratum appears in Nat Genet 1993 Aug;4(4):431]. Nat Genet 2:113, 1992
68. Dhordain P, Albagli O, Ansieau S, Koken MH, Deweindt C, Quief S, Lantoine D, Leutz A, Kerckaert JP, Leprince D: The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. Oncogene 11:2689, 1995
69. Naf D, Kupfer GM, Suliman A, Lambert K, D'Andrea AD: Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization. Mol Cell Biol 18:5952, 1998
70. Savoia A, Garcia-Higuera I, D'Andrea AD: Nuclear localization of the Fanconi anemia protein FANCC is required for functional activity [letter]. Blood 93:4025, 1999
71. Hong SH, Wong CW, Privalsky ML: Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor. Mol Endocrinol 12:1161, 1998
72. Wong CW, Privalsky ML: Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J Biol Chem 273:27695, 1998
73. Wong CW, Privalsky ML: Transcriptional repression by the SMRT-mSin3 corepressor: Multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol 18:5500, 1998
74. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB: p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1:570, 1995
75. Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, Dong S, Chen S, Chen Z, Tan CC, Licht J, Waxman S, de The H, Zelent A: Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci USA 94:10255, 1997
76. Hong SH, Privalsky ML: Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha. J Biol Chem 274:2885, 1999
77. Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A, Licht JD: The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol Cell Biol 18:5533, 1998
78. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A, Licht JD: Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18:925, 1999
79. Kupfer G, Naf D, Garcia-Higuera I, Wasik J, Cheng A, Yamashita T, Tipping A, Morgan N, Mathew CG, D'Andrea AD: A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation. Exp Hematol 27:587, 1999
80. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265, 1997
81. Borden KL, Campbelldwyer EJ, Carlile GW, Djavani M, Salvato MS: Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 72:3819, 1998
82. Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M, Szekely L, Helin K, Pelicci PG: The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 18:1084, 1998
83. Lo ten Foe JR, Barel MT, Thuss P, Digweed M, Arwert F, Joenje H: Sequence variations in the Fanconi anaemia gene, FAC: Pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant. Hum Genet 98:522, 1996